Fortress Biotech, Inc. (FBIO)

Fortress Biotech Revenue

Fortress Biotech had revenue of $85.11M in the twelve months ending March 31, 2024, with 32.48% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $13.03M with 4.84% year-over-year growth. In the year 2023, Fortress Biotech had annual revenue of $84.51M with 11.58% growth.

• Revenue (ttm): $85.11M
• Revenue Growth: +32.48%
• P/S Ratio: 0.52
• Revenue / Employee: $457,602
• Employees: 186
• Market Cap: 43.89M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	84.51M	8.77M	11.58%
Dec 31, 2022	75.74M	6.95M	10.11%
Dec 31, 2021	68.79M	23.19M	50.86%
Dec 31, 2020	45.60M	8.97M	24.49%
Dec 31, 2019	36.63M	9.75M	36.26%
Dec 31, 2018	26.88M	9.64M	55.88%
Dec 31, 2017	17.25M	765.00K	4.64%
Dec 31, 2016	16.48M	15.62M	1,809.62%
Dec 31, 2015	863.00K	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.